Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 23, 2013BloodOpen Access

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

ERElisa RumiDPDaniela PietraVFVirginia Valeria Ferretti

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rumi et al. (2013) studied this question.

synapsesocial.com/papers/69da574f84371aa676a3d1dbhttps://doi.org/10.1182/blood-2013-11-539098
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis2009 · 143 citations
  2. 2The Analysis of Failure Times in the Presence of Competing Risks1978 · 1,564 citations
  3. 3Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms2013 · 2,021 citations
  4. 4Kaplan—meier, marginal or conditional probability curves in summarizing competing risks failure time data?1993 · 633 citations
  5. 5JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone2012 · 107 citations